These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 4468021)
21. Rifampicin/pyrazinamide therapy should not be used for latent tuberculosis infection. Garca-Doval I J Am Acad Dermatol; 2004 May; 50(5):801; author reply 801-2. PubMed ID: 15097974 [No Abstract] [Full Text] [Related]
22. Pharmaceutical formulation of a fixed-dose anti-tuberculosis combination. Danckwerts MP; Ebrahim S; Pillay V Int J Tuberc Lung Dis; 2003 Mar; 7(3):289-97. PubMed ID: 12661846 [TBL] [Abstract][Full Text] [Related]
23. [The simultaneous use of rifampicin and other antitubercular agents with oral contraceptives]. Reimers D; Jezek A Prax Pneumol; 1971 May; 25(5):255-62. PubMed ID: 5556355 [No Abstract] [Full Text] [Related]
29. Rifampicin and ethambutol in the treatment of drug resistant and far advanced pulmonary tuberculosis (with a note on capreomycin). Pines A; Raafat H; Siddiqui GM J Ir Med Assoc; 1970 Mar; 63(393):82-5. PubMed ID: 4984340 [No Abstract] [Full Text] [Related]
30. The intermittent chemotherapy of tuberculosis with rifampicin regimens on ambulatory basis. Anastasatu C; Bungeteanu G; Sibila S Scand J Respir Dis Suppl; 1973; 84():136-9. PubMed ID: 4522068 [No Abstract] [Full Text] [Related]
31. Side effects during intermittent rifampicin and ethambutol treatment. A preliminary report. Guerra Sanz FJ Scand J Respir Dis Suppl; 1973; 84():160-5. PubMed ID: 4522071 [No Abstract] [Full Text] [Related]
32. [Treatment of experimental tuberculosis in guinea pigs by continuous and intermittent regimen with special reference to ethambutol and rifampicin]. Westfal I; Wiza J; Rudnicka M; Szymaczek-Meyer L Gruzlica; 1973 Jan; 41(1):1-8. PubMed ID: 4686876 [No Abstract] [Full Text] [Related]
33. [Current views on drug treatment of tuberculosis]. Repo UK Nord Med; 1970 Jun; 83(26):809-11. PubMed ID: 5432095 [No Abstract] [Full Text] [Related]
34. [Drug-resistant pulmonary tuberculosis at the penitentiaries]. Kononets AS Probl Tuberk Bolezn Legk; 2008; (12):60-3. PubMed ID: 19227326 [TBL] [Abstract][Full Text] [Related]
36. [Current views on drug treatment of tuberculosis]. Repo K; Riska N Duodecim; 1970; 86(21):1268-78. PubMed ID: 5490929 [No Abstract] [Full Text] [Related]
37. [Effect of schizophyllan in experimental tuberculosis]. Komatsu N; Nagumo N; Amemiya K; Kato M; Saga K Jpn J Antibiot; 1973 Oct; 26(5):459-69. PubMed ID: 4271543 [No Abstract] [Full Text] [Related]
38. Optic neuritis and bitemporal hemianopsia associated with isoniazid treatment in end-stage renal failure. Kocabay G; Erelel M; Tutkun IT; Ecder T Int J Tuberc Lung Dis; 2006 Dec; 10(12):1418-9. PubMed ID: 17171829 [No Abstract] [Full Text] [Related]
39. [Rifampicin; its value and its limitations in tuberculosis, chronic or of severe onset, with or without associated ethambutol]. Tricoire J; Marécaux L Rev Tuberc Pneumol (Paris); 1969 Mar; 33(2):226-41. PubMed ID: 5385585 [No Abstract] [Full Text] [Related]
40. [Drug therapy of tuberculosis. Advanced training and working conference at the Central Hospital Gauting of the State Insurance Company of Upper Bavaria on Nov. 9, 1968]. Erhard G Med Klin; 1969; 64(26):1215-7. PubMed ID: 4979959 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]